Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.

BACKGROUND Non-insulin-dependent diabetes mellitus (NIDDM) is a major cause of end-stage renal disease. However, the course and determinants of renal failure in this type of diabetes have not been clearly defined. METHODS We studied glomerular function at intervals of 6 to 12 months for 4 years in 194 Pima Indians selected to represent different stages in the development and progression of diabetic renal disease. Initially, 31 subjects had normal glucose tolerance, 29 had impaired glucose tolerance, 30 had newly diagnosed diabetes, and 104 had had diabetes for five years or more; of these 104, 20 had normal albumin excretion, 50 had microalbuminuria, and 34 had macroalbuminuria. The glomerular filtration rate, renal plasma flow, urinary albumin excretion, and blood pressure were measured at each examination. RESULTS Initially, the mean (+/-SE) glomerular filtration rate was 143+/-7 ml per minute in subjects with newly diagnosed diabetes, 155+/-7 ml per minute in those with microalbuminuria, and 124+/-7 ml per minute in those with macroalbuminuria; these values were 16 percent, 26 percent, and 1 percent higher, respectively, than in the subjects with normal glucose tolerance (123+/-4 ml per minute). During four years of follow-up, the glomerular filtration rate increased by 18 percent in the subjects who initially had newly diagnosed diabetes (P=0.008); the rate declined by 3 percent in those with microalbuminuria at base line (P=0.29) and by 35 percent in those with macroalbuminuria (P<0.001). Higher base-line blood pressure predicted increasing urinary albumin excretion (P=0.006), and higher base-line urinary albumin excretion predicted a decline in the glomerular filtration rate (P<0.001). The initial glomerular filtration rate did not predict worsening albuminuria. CONCLUSIONS The glomerular filtration rate is elevated at the onset of NIDDM and remains so while normal albumin excretion or microalbuminuria persists. It declines progressively after the development of macroalbuminuria.

[1]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[2]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[3]  G. Beck,et al.  Progression of overt nephropathy in non-insulin-dependent diabetes. , 1995, Kidney international.

[4]  R. Hanson,et al.  Incidence and Determinants of Elevated Urinary Albumin Excretion in Pima Indians With NIDDM , 1995, Diabetes Care.

[5]  B. Kristal,et al.  Structural basis for reduced glomerular filtration capacity in nephrotic humans. , 1994, The Journal of clinical investigation.

[6]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[7]  H. Parving,et al.  Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. , 1992, Kidney international.

[8]  P. Bennett,et al.  Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. , 1991, Archives of internal medicine.

[9]  P. Savage,et al.  Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. , 1989, The New England journal of medicine.

[10]  B. Myers,et al.  Charge Selectivity of Proteinuria in Diabetic Glomerulopathy , 1988, Diabetes.

[11]  B. Brenner,et al.  Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans. , 1985, The American journal of physiology.

[12]  M. Steffes,et al.  Structural-functional relationships in diabetic nephropathy. , 1984, The Journal of clinical investigation.

[13]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[14]  B. Brenner,et al.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. , 1982, The American journal of medicine.

[15]  B. Brenner,et al.  Glomerular hemodynamics in experimental diabetes mellitus. , 1981, Kidney international.

[16]  J. Soeldner,et al.  Quantitiative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. , 1980, Clinical chemistry.

[17]  P. Bennett,et al.  Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. , 1978, American journal of epidemiology.

[18]  B. Brenner,et al.  Permselectivity of the glomerular capillary wall to macromolecules. I. Theoretical considerations. , 1975, Biophysical journal.